Revelation Biosciences Inc (REVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,039 | -120 | -10,830 | -11,987 | -1,631 |
| Depreciation Amortization | 28 | 25 | 25 | 17 | N/A |
| Accounts payable and accrued liabilities | -576 | 750 | -666 | -270 | N/A |
| Other Working Capital | -3,423 | 982 | -731 | 356 | -81 |
| Other Operating Activity | 689 | -8,923 | 982 | 793 | 1,494 |
| Operating Cash Flow | $-18,321 | $-7,286 | $-11,219 | $-11,091 | $-217 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | -527 |
| PPE Investments | -19 | N/A | N/A | -132 | N/A |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -73,509 |
| Investing Cash Flow | $-19 | $N/A | $N/A | $-132 | $-74,036 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 290 |
| Debt Issued | N/A | N/A | 2,500 | N/A | N/A |
| Debt Repayment | N/A | N/A | -2,500 | N/A | N/A |
| Common Stock Issued | 12,848 | 14,030 | 4,456 | 600 | 74,559 |
| Common Stock Repurchased | N/A | N/A | -7,652 | N/A | N/A |
| Other Financing Activity | 0 | -5 | 18,394 | 7,405 | -585 |
| Financing Cash Flow | $12,848 | $14,025 | $15,198 | $8,005 | $74,265 |
| Beginning Cash Position | 11,992 | 5,253 | 1,275 | 4,492 | N/A |
| End Cash Position | 6,499 | 11,992 | 5,253 | 1,275 | 12 |
| Net Cash Flow | $-5,493 | $6,739 | $3,978 | $-3,218 | $12 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,321 | -7,286 | -11,219 | -11,091 | -217 |
| Capital Expenditure | -19 | N/A | N/A | -132 | N/A |
| Free Cash Flow | -18,341 | -7,286 | -11,219 | -11,223 | -217 |